Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Mitsudomi

Showing results (11-20 of 336) with videos related to

Pageof 34
Sort By:
The FEBS Journal|November 20, 2009
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancerTetsuya Mitsudomi, Yasushi Yatabe
Cells|July 2, 2021
Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> MutationsKenichi Suda, Tetsuya Mitsudomi
General Thoracic and Cardiovascular Surgery|March 15, 2008
Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancersTakayuki Fukui, Tetsuya Mitsudomi
Cancer Science|September 25, 2007
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancerTetsuya Mitsudomi, Yasushi Yatabe
Kyobu Geka. the Japanese Journal of Thoracic Surgery|March 6, 2022
[Current Status and Future Perspectives of Molecular Targeted Therapies for Lung Cancer]Kenichi Suda, Tetsuya Mitsudomi
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Postoperative adjuvant chemotherapy for lung, gastric, colorectal and breast cancers]Takayuki Fukui, Tetsuya Mitsudomi
Archives of Toxicology|May 19, 2015
Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivityKenichi Suda, Tetsuya Mitsudomi
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Development of personalized treatments in lung cancer: focusing on the <i>EGFR</i> mutations and beyondKenichi Suda, Tetsuya Mitsudomi
Translational Lung Cancer Research|March 26, 2015
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?Yoshihisa Kobayashi, Tetsuya Mitsudomi
Nihon Geka Gakkai Zasshi|June 21, 2014
[Development of molecular targeted therapies in lung cancers]Kenichi Suda, Tetsuya Mitsudomi
Pageof 34

Showing results (11-20 of 336) with videos related to

Sort By:
Pageof 34
The FEBS Journal|November 20, 2009
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancerTetsuya Mitsudomi, Yasushi Yatabe
Cells|July 2, 2021
Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> MutationsKenichi Suda, Tetsuya Mitsudomi
General Thoracic and Cardiovascular Surgery|March 15, 2008
Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancersTakayuki Fukui, Tetsuya Mitsudomi
Cancer Science|September 25, 2007
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancerTetsuya Mitsudomi, Yasushi Yatabe
Kyobu Geka. the Japanese Journal of Thoracic Surgery|March 6, 2022
[Current Status and Future Perspectives of Molecular Targeted Therapies for Lung Cancer]Kenichi Suda, Tetsuya Mitsudomi
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Postoperative adjuvant chemotherapy for lung, gastric, colorectal and breast cancers]Takayuki Fukui, Tetsuya Mitsudomi
Archives of Toxicology|May 19, 2015
Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivityKenichi Suda, Tetsuya Mitsudomi
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Development of personalized treatments in lung cancer: focusing on the <i>EGFR</i> mutations and beyondKenichi Suda, Tetsuya Mitsudomi
Translational Lung Cancer Research|March 26, 2015
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?Yoshihisa Kobayashi, Tetsuya Mitsudomi
Nihon Geka Gakkai Zasshi|June 21, 2014
[Development of molecular targeted therapies in lung cancers]Kenichi Suda, Tetsuya Mitsudomi
Pageof 34